Results 161 to 170 of about 211,038 (237)
Structural basis of tethered agonism and G protein coupling of protease-activated receptors. [PDF]
Guo J +9 more
europepmc +1 more source
Possible Involvement of Thrombin/Protease-Activated Receptor 1 System in the Pathogenesis of Endometriosis [PDF]
Yasushi Hirota +10 more
openalex +1 more source
3D printed hybrid scaffolds combining bioactive silica–calcium chemistry with elastic polymers guide human bone stem cells to form bone. The scaffolds support cell survival, organization, and invasion while releasing osteogenic ions. Together, architecture and composition drive bone‐specific gene expression, extracellular matrix organization, and ...
David R. Sory +3 more
wiley +1 more source
New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy. [PDF]
Jiang Y, Lu L.
europepmc +1 more source
Matrix metalloproteinases target protease-activated receptors on the tumor cell surface [PDF]
Duanqing Pei
openalex +1 more source
Intranasally administered hUMSC‐derived exosomes modulate the CRYAB–ARRDC3–Drp1 axis, alleviating mitochondrial dysfunction and ferroptosis, enhancing neuronal survival, reducing oxidative stress, and promoting functional recovery in ischemia‐reperfusion injury, offering a promising therapeutic strategy for ischemic stroke.
Rong ji +7 more
wiley +1 more source
Characterizing Modulators of Protease-activated Receptors with a Calcium Mobilization Assay Using a Plate Reader. [PDF]
DeRousse JT, Dockendorff C.
europepmc +1 more source
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández +4 more
wiley +1 more source
PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs. [PDF]
Nag JK +4 more
europepmc +1 more source

